CONTENT INTRODUCTION«««««««««««««..2 PATIENT·S BACKGROUND««««««««..3 CLINICAL FEATURES«««««««««««.4 PHYSICAL ASSESSMENT««««««««««5…

Slide 1Prediction of Xenobiotic Metabolism and Major Metabolites György Pirok Solutions for Cheminformatics Slide 2 The KnowTox project hepatotoxicity toxicity metabolism…

Slide 1HELMINTHES Flat worms and Round worms Slide 2 Slide 3 HELMINTHOLOGY Phylum Platyhelminthes = Flat worms Class Trematoda = Flukes Class Cestoda = Tape worms Phylum…

1. 1Is One R the new Three Rs?Lisbeth E. KnudsenProfessor, PhD, University of Copenhagen, Department of Public [email protected] MathiesenThit Aarøe MørckPernille…

Slide 1Patricia S. Steeg, Ph.D. Director, Molecular Therapeutics Program Chief, Women’s Cancers Section, Laboratory of Pathology National Cancer Institute Bethesda, MD…

Slide 1 Clinical Trial Design, Biostatistics, Ethics, and Recruitment Clinical Trial Design  Anthony J. Murgo, MD.,MS; NCI/DCTD Biostatistics  Larry Rubinstein, PhD;…

Development of an integrated database for the management of accidental spills (DIMAS) Katrien Arijs Bram Versonnen Marnix Vangheluwe Jan Mees Ward Vandenberghe Daphne Cuvelier…

Phase 0 Trials Role in Radiation Mitigation Agent Development? Anthony J. Murgo, M.D., M.S. Office of Oncology Drug Products Center for Drug Evaluation and Research Food…

PowerPoint Presentation An integrated European effort to develop vaginal/rectal HIV preventive drugs Guido Vanham and Kevin Ariën, Virology Unit, Institute of Tropical Medicine,…

Subacute Necrotizing Encephalomyopathy (Leigh's Disease) Advances in Mitochondrial Disease Darius J. Adams, M.D. Genetics and Metabolism Diagnostics and Therapeutics…